Drug lowers body's 'set point' to control hyperparathyroidism in dialysis patients

A medication called cinacalcet—an important part of treatment to control high levels of parathyroid hormone (PTH) in patients receiving dialysis for end-stage renal disease (ESRD)—works by resetting the balance between calcium and PTH levels, according to a study in the November Journal of the American Society of Nephrology (JASN).

Read the whole article on Physorg

More from Physorg